carboplatin,etoposide,atezolizumab,tiragolumab
roche
['skyscraper-02', 'lung', 'lcsm,(-blcsm)', 'tiragolumab', 'sclc']
skyscraper-02 trial: tiragolumab added to standard of care fails to extend survival in #sclc #asco22 #ascodailynews #lungcancer #lcsm
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ? endorse.